Sartorius (SRT.DE) Financial Analysis & Valuation | Quarter Chart
Sartorius (SRT.DE)
SRT.DEPrice: $214.65
Fair Value: 🔒
🔒score
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagen... more
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. ... more
Description
Shares
| Market Cap | $18.02B | Exchange | XETRA |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | DE | CEO | Michael Grosse |
| IPO Date | 1999-04-06 | CAGR | 0.09% |
| Employees | 13,573 | Website | www.sartorius.com |
| Div. Yield | 0.32% | Payout Ratio | 0.62% |
| Buy Back Yield | — | Total Yield | 0.32% |
SRT.DE chart loading...
Fundamentals
Technicals
| Enterprise Value | $21.63B | P/E Ratio | 39.45 |
| Forward P/E | 28.17 | PEG Ratio | — |
| P/S Ratio | 4.52 | P/B Ratio | 5.91 |
| P/CF Ratio | 22.69 | P/FCF Ratio | 60.59 |
| EPS | $5.44 | EPS Growth 1Y | 69.06% |
| EPS Growth 3Y | -77.91% | EPS Growth 5Y | -39.74% |
| Revenue Growth 1Y | 3.2% | Gross Margin | 0.46% |
| Operating Margin | 0.17% | Profit Margin | 0.05% |
| ROE | 0.06% | ROA | 0.02% |
| ROCE | 0.08% | Current Ratio | 0.91 |
| Quick Ratio | 0.52 | Cash Ratio | 0.27 |
| Debt/Equity | 1.58 | Interest Coverage | 2.44 |
| Altman Z Score | 2.48 | Piotroski Score | 6 |